Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review (Q40442625)

From Wikidata

Revision as of 01:10, 12 June 2024 by Cewbot (talk | contribs) (‎Removed claim: author name string (P2093): Pelkonen O, Modify PubMed ID: 7607565 citation data from NCBI, Europe PMC and CrossRef)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on June 14, 1995

Language	Label	Description	Also known as
English	Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review	scientific article published on June 14, 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review (English)

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

restriction fragment length polymorphism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

author name string

H. Raunio

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

K. Husgafvel-Pursiainen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

S. Anttila

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

E. Hietanen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

A. Hirvonen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

O. Pelkonen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607565

12 June 2024

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

14 June 1995

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607565

12 June 2024

full work available at URL

https://api.elsevier.com/content/article/PII:0378111994004482?httpAccept=text/xml

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

https://api.elsevier.com/content/article/PII:0378111994004482?httpAccept=text/plain

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

159

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

113-121

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Debrisoquin oxidation genotype and susceptibility to lung cancer

1

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients

2

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer.

4

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer

6

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Molecular mechanism of slow acetylation of drugs and carcinogens in humans

7

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence

9

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu)

10

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer.

11

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Human cytochromes P450: problems and prospects

13

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Identification of the primary gene defect at the cytochrome P450 CYP2D locus

14

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Genetic Linkage of Lung Cancer-Associated MspI Polymorphisms with Amino Acid Replacement in the Heme Binding Region of the Human Cytochrome P450IA1 Gene1

16

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

17

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes

18

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.

19

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours

20

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

21

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans

22

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population.

25

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung

26

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers

27

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

An Mspl RFLP in the human ARNT gene, encoding a subunit of the nuclear form of the Ah (dioxin) receptor

29

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk

30

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene

31

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

The CYP1A1 gene and cancer susceptibility

32

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer

33

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure.

34

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

35

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population

37

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

38

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Carcinogen metabolism and individual susceptibility

39

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6.

41

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse

46

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Interindividual variability of coumarin 7-hydroxylation in healthy volunteers

48

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Stereoselective metabolism of (—)-benzo [a]pyrene-7,8-diol by human lung microsomes and peripheral blood lymphocytes: effect of smoking

49

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients

50

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study

52

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Polycyclic aromatic hydrocarbon-DNA adducts and the CYP1A1 restriction fragment length polymorphism

53

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Human CYP1A1 (cytochrome P1450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population

54

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer

56

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure

57

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Comparison of the formation of benzo[a]pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2.

58

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μ

60

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens

61

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.

64

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer

65

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility.

66

1 reference

10.1016/0378-1119(94)00448-2

https://api.crossref.org/works/10.1016/0378-1119(94)00448-2

12 June 2024

Identifiers

10.1016/0378-1119(94)00448-2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40442625&oldid=2176843604"